Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$1.66 - $2.41 $38,027 - $55,208
22,908 Added 1.38%
1,687,868 $3.88 Million
Q2 2023

Aug 14, 2023

BUY
$1.52 - $2.78 $779,608 - $1.43 Million
512,900 Added 44.52%
1,664,960 $2.6 Million
Q1 2023

May 15, 2023

SELL
$2.36 - $3.35 $236,000 - $335,000
-100,000 Reduced 7.99%
1,152,060 $2.91 Million
Q4 2022

Feb 14, 2023

SELL
$2.58 - $4.68 $903,000 - $1.64 Million
-350,000 Reduced 21.85%
1,252,060 $3.37 Million
Q3 2022

Nov 14, 2022

BUY
$2.7 - $4.3 $4.15 Million - $6.61 Million
1,536,410 Added 2340.3%
1,602,060 $4.41 Million
Q4 2021

Feb 14, 2022

SELL
$7.03 - $13.03 $4.96 Million - $9.19 Million
-705,544 Reduced 91.49%
65,650 $462,000
Q3 2021

Nov 15, 2021

BUY
$11.11 - $17.84 $8.57 Million - $13.8 Million
771,194 New
771,194 $8.71 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $862M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Alyeska Investment Group, L.P. Portfolio

Follow Alyeska Investment Group, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.